Elevance Health's $390M Volume Dips 58.5% to 214th Rank as Shares Slide 0.81%

Generated by AI AgentAinvest Market Brief
Monday, Aug 25, 2025 7:44 pm ET1min read
Aime RobotAime Summary

- Elevance Health’s trading volume dropped 58.51% to $390M on Aug 25, ranking 214th, with shares down 0.81%.

- Reduced volume aligns with broader market consolidation, as investors await its Sept quarterly report.

- A volume-based strategy (Dec 2021–Aug 2025) generated $2,940 profit but faced -$1,960 max drawdown, highlighting moderate risk.

- Dec 2021 was the strongest month ($840 gain), while Aug 2025 recorded the worst performance ($790 loss).

On August 25, 2025,

(ELV) reported a trading volume of $0.39 billion, a 58.51% decline from the previous day, ranking it 214th in daily trading activity. The stock closed down 0.81% for the session.

The muted volume suggests reduced short-term investor engagement, aligning with broader market consolidation patterns observed in recent weeks. While no direct earnings or regulatory updates were reported, the stock’s performance reflects cautious positioning ahead of the company’s upcoming quarterly report in September.

A strategy analyzing the top 500 stocks by daily trading volume from December 2021 to August 2025 showed a total profit of $2,940, with a Sharpe ratio of 1.53. The maximum drawdown reached -$1,960 during the same period, indicating moderate risk exposure. December 2021 was the strongest month, generating $840 in gains, while August 2025 recorded the worst performance with a $790 loss.

Comments



Add a public comment...
No comments

No comments yet